Presentation highlights progress in psoriasis and psoriatic arthritis projects, indicating ongoing collaboration and educational efforts.
Significant progress toward several key initiatives was presented during the Project Key Advances session of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting. Highlights included advancements from the Collaborative Research Network (CRN), with contributions from the Health Initiatives in Psoriasis and Psoriatic Arthritis Consortium European States (HIPPOCRATES) and developments in the complex-to-manage (C2M)/difficult-to-treat (D2T) psoriatic arthritis project. The presentation also included an update on the GRAPPA educational slide library. These activities underscore GRAPPA's continued dedication to fostering collaboration that advances psoriatic disease education and research toward improved patient outcomes.
No takes yet. Share an insight, caveat, or question.
Ayan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: